JOSEPH GALASKE: Open Payments
NPI 1568112308 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 21 payments from 11 companies in 2025. Trend: 2023 $983 · 2024 $1,459 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $92 |
| Amgen Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ABBVIE INC. | 2 | $40 |
| Viatris Specialty LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: FREESTYLE LIBRE 3, OTEZLA, YUPELRI, Ozempic, Auvelity, UBRELVY, BREZTRI, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
